State of cardiac resynchronization therapy in Spain. Number of implants for inhabitant: Comparison with data from other countries and differences between autonomous communities;Resincronización en España. Implantes por habitante: Datos comparativos

Revista Espanola de Cardiologia Suplementos

Volumn 5, Issue B, 2005, Pages

  Fernández Lozano, Ignacio ^a   Brugada Terradellas, Josep ^b   Belaza, Javier ^c  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c Cardioforum   (Spain)

Author keywords

Cardiac resynchronization therapy; Epidemiology; Heart failure; Implantable defibrillator

Indexed keywords

BELGIUM; EUROPE; FRANCE; HEART CONTRACTION; HEART FAILURE; HUMAN; IMPLANTATION; ITALY; PACEMAKER; PORTUGAL; REVIEW; SPAIN; SWEDEN; SWITZERLAND;

EID: 33847631683     PISSN: 11313587     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, Tex. Disponible en: www.americanheart.org
2. Rodríguez-Artalejo F, Banegas Banegas JR, Guallar-Castillón P. Epidemiología de la insuficiencia cardíaca. Rev Esp Cardiol. 2004;57:163-70.
3. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KL, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-402.
4. Gottipaty VK. The resting electrocardiogram provides a sensitive and inexpensive marker or prognosis in patients with chronic heart failure (abstract). J Am Coll Cardiol. 1999;33 Suppl:A145.
5. Xiao HB, Roy C, Fujimoto S, Gibson DG. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Card. 1996;53:163-70.
6. Aaronson KD, Scheartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660-7.
7. Shamim W, Francis DP, Yousufuddin M, Varney S, Pieopli MF, Anker SD, et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol. 1999;70:171-8.
8. Nelson GS, Berger RD, Fetics BJ, Talbot M, Spinelli JC, Hare JM, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 2000;102:3053-9.
9. De Teresa PA, Chamorro JL, Pulpón LA, Ruiz C, Rodríguez Bailón I, Alzueta J, et al. An even more physiological pacing: changing the sequence of ventricular activation. Vienna: Proceedings, VIIth World Symposium of Cardiac Pacing; 1983. p. 95-100.
10. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al, for the MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-53.
11. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al, for the Multisite Stimulation In Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873-80.
12. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, et al. Cardiac resynchronization and death from progressive heart failure. A meta-analysis of randomized controlled trials. JAMA. 2003;289:730-40.
13. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50.
14. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation. 2002;106:214-61.
15. Rodríguez Artalejo F, Guallar-Castillón P, Banegas Banegas JR, Rey Calero J. Trends in hospitalization and mortality for congestive heart failure in Spain, 1980-1993. Eur Heart J. 1997;18:1771-9.
16. Brotons C, Moral I, Ribera A, Pérez G, Cascant P, Bustins M, et al. Tendencias de la morbimortalidad por insuficiencia cardíaca en Cataluña. Rev Esp Cardiol. 1998;47:633-7.
17. Cortina A, Reguero J, Segovia E, Rodríguez Lambert JL, Cortina R, Arias JC, et al. Prevalence of heart failure in Asturias (a region in the North of Spain). Am J Cardiol. 2001;87:1417-9.
18. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000;83:596-602.
19. National Heart, Lung and Blood Institute. Data fact sheet, congestive heart failure in the United States: a new epidemic. Disponible en: www.nhlbi.nih.gov.
20. Farwell D, Patel NR, Hall A, Ralph S, Sulke AN. How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J. 2000;21:1246-50.
21. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37.